
Bioorganic and Medicinal Chemistry Letters p. 6102 - 6106 (2006)
Update date:2022-08-04
Topics:
Bullington, James
Argentieri, Dennis
Averill, Kristin
Carter, Demetrius
Cavender, Druie
Fahmy, Bohumila
Fan, Xiaodong
Hall, Daniel
Heintzelman, Geoffrey
Jackson, Paul
Leung, Wai-Ping
Li, Xun
Ling, Ping
Olini, Gilbert
Razler, Thomas
Reuman, Michael
Rupert, Kenneth
Russell, Ronald
Siekierka, John
Wadsworth, Scott
Wolff, Russell
Xiang, Bangping
Zhang, Yue-Mei
Inhibition of the p38 map kinase pathway has been shown to be beneficial in the treatment of inflammatory diseases. The first class of potent p38 kinase inhibitors was the pyridinylimidazole compounds from SKB. Since then several pyridinylimidazole-based
View MoreShijiazhuang Sdyano Fine Chemical Co., Ltd
Contact:+86-311-89830448
Address:NO.48 Ta Nan Road,Yuhua District,Shijiazhuang,Hebei,China
HANGZHOU FOREWIN PHARMA CO., LTD
Contact:+86-571-89053961
Address:hangzhou
website:http://www.cartoonchem.com/
Contact:+86-25-58074918
Address:Room 2109, RuiHua Business Center,315 South ZhongShan Road, Nanjing 210001, China
Xiamen Kaijia Imp & Exp Co., Ltd.
Contact:86-592-5101177
Address:Room406 Luhui Building No. 65 Haitian Road Huli Xiamen,China.
Beijing Top Science biological technology co., LTD
Contact:+86-13439059536
Address:15-1705 jre three mile, Beijing 100000,CHINA
Doi:10.1021/ja110224d
(2011)Doi:10.1016/j.ejmech.2003.11.007
(2004)Doi:10.1016/S0960-894X(02)00191-9
(2002)Doi:10.1016/j.bmcl.2010.08.106
(2010)Doi:10.1016/j.ica.2010.02.030
(2010)Doi:10.1002/ejoc.201000796
(2010)